| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN |
|---|
| 224.1 | G04CA01 | alfuzosin | p.o. | 7.5 | MG | 20,00 | L/URN |
| 224.2 | G04CA01 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 20,00 | L/URN |
| 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 20,00 | L/URN |
| 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 16,80 | L/URN |
| 44311 | KORNAM 2MG | tbl 30x2mg | LEK | SLO |
| 44312 | KORNAM 5MG | tbl 30x5mg | LEK | SLO |
| 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 20,00 | L/URN | |
| 224.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2 | DF | 16,00 | L/URN | |
| 224.7 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 2 a víckrát denně) | p.o. | 2 | DF | 16,00 | L/URN | |
| 57898 | SPALDA SABAL 160MG | cps 200x160mg | KKA | D |
| 57897 | SPALDA SABAL 160MG | cps 120x160mg | KKA | D |
| 57896 | SPALDA SABAL 160MG | cps 60x160mg | KKA | D |
| 224.8 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 1x denně) | p.o. | 1 | DF | 16,00 | L/URN |
| 59710 | PROSTAMOL UNO | cps 30x320mg | BCE | D |
| 57893 | SPALDA SABAL 320MG | cps 60x320mg | KKA | D |
| 57894 | SPALDA SABAL 320MG | cps 120x320mg | KKA | D |
| 57895 | SPALDA SABAL 320MG | cps 200x320mg | KKA | D |
| 224.9 | G04CX03 | mepartricin | p.o. | 150 | KU | 20,00 | L/URN |
| 225 | H01A | hormony předního laloku hypofýzy | parent. |
|---|
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59,93 | L/END |
| 225.2 | H01AC01 | somatropin | parent. | 2 | U | 705,00 | L/J5 |
| 226 | H01BA | vasopresin a jeho deriváty | parent. | H |
|---|
| 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 82,41 | O |
| 226.2 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1 | MG | 288,08 | H |
| 226.3 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1 | MG | 245,27 | H |
| 226.4 | H01BA05 | ornipresin | parent. | 5 | U | 27,57 | H |
| 227 | H01BA | vasopresin a jeho deriváty | lok. |
|---|
| 227.1 | H01BA02 | desmopresin (nosní kapky) | lok. | 25 | RG | 22,89 |
| 02634 | ADIURETIN | gtt nas 1x5ml/0.5mg | FRL | CZ |
| 227.2 | H01BA02 | desmopresin (nosní spray) | lok. | 25 | RG | 22,89 | |
| 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 22,89 | |
| 228 | H01BB | oxytocin a jeho deriváty | parent. | H |
|---|
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 49,20 | H |
| 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ |
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 21,96 | H |
| 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ |
| 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z |
|---|
| 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,34 | Z |
| 229.2 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0,4 | MG | 147,61 | Z |
| 45481 | SYNAREL | spr nas 1x4ml | SEA | POR |
| 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z |
| 83795 | SYNAREL | spr nas 1x8ml | SEA | POR |
| 229.4 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu ) | parent. | 0,25 | MG | 1600,00 | Z |
| 05981 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | IRL |
| 05980 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | NL |
| 05979 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | NL |
| 05982 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | IRL |
| 229.5 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0,25 MG | 1600,00 | Z |
| 229.6 | H01CC02 | cetrorelix s obsahem 3 mg v 1 ampuli | parent. | 0,25 MG | 667,00 | Z |
| 230 | H01CB | somatostatin a jeho deriváty | parent. | X |
|---|
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 7754,00 | X |
| 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B |
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5016,00 | X |
| 93867 | SANDOSTATIN | inj 1x5ml/1mg-lahv. | SAN | CH |
| 93866 | SANDOSTATIN | inj 5x1ml/0.5mg | SAN | CH |
| 230.3 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 10 mg | parent. | 0,35 7 | MG | 1378,40 | X |
| 230.4 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 20 mg | parent. | 0,71 4 | MG | 1840,57 | X |
| 230.5 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 30 mg | parent. | 1,07 2 | MG | 2297,30 | X |
| 230.6 | H01CB03 | lantreotid | parent. | 2,14 | MG | 1789,03 | X |
| 84701 | SOMATULINE P.R. | inj sic 1x30mg+solv | IPE | F |
| 231 | H02AA | mineralokortikoidy | p.o. |
|---|
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,76 |
| 232 | H02AB | glukokortikoidy | p.o. |
|---|
| 232.1 | H02AB01 betamethason | p.o. | 1.5 | MG | 3,42 | ||
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 9,42 | |
| 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,42 | |
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | |
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,43 | |
| 86606 | MEDROL 16MG | tbl 50x16mg(blistr) | PAU | B |
| 232.6 | H02AB07 | prednison | p.o. | 10 | MG | 3,21 |
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ |
| 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ |
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | |
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,07 | |
| 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D |
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,07 |
| 80588 | CORTISON CIBA 25MG | tbl 100x25mg | CGC | CH |
| 232.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,30 | |
| 232.11 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10 | MG | 4,59 | |
| 232.12 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,16 | |
| 233 | H02AB | glukokortikoidy | parent. | O |
|---|
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O |
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 3,28 | O |
| 89869 | DIPROPHOS | inj 5x1ml | SCH | B |
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F |
| 233.3 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. 1.5 | MG | 2,21 | O |
| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY |
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY |
| 233.4 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 24,50 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D |
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 35,70 | O |
| 233.6 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,11 | O |
| 233.7 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O |
| 233.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,46 | O |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D |
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O |
| 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D |
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O |
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O |
| 234 | H03AA | hormony štítné žlázy | p.o. |
|---|
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 |
| 61160 | JODTHYROX | tbl 50 | MEC | D |
| 61161 | JODTHYROX | tbl 100 | MEC | D |
| 234.2 | H03AA01 | levothyroxin sodný (do 50 rg v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 |
| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D |
| 47141 | LETROX 50 | tbl 100x50rg | BCE | D |
| 234.3 | H03AA01 | levothyroxin sodný (nad 50 rg do 100 rg včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 |
| 47144 | LETROX 100 | tbl 100x100rg | BCE | D |
| 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D |
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 rg v 1 tabletě) | p.o. | 0.15 | MG | 1,12 |
| 69191 | EUTHYROX 150 | tbl 100x150rg | MEC | D |
| 47133 | LETROX 150 | tbl 100x150rg | BCE | D |
| 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,40 |
| 09805 | TERTROXIN | tbl 100x0.02mg | GLA | ZA |
| 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 |
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D |
| 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,81 |
| 61158 | JODID 100 | tbl 100 | MEC | D |
| 61159 | JODID 200 | tbl 100 | MEC | D |
| 235 | H03B | thyreostatika | p.o. |
|---|
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,04 | |
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 3,11 | |
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK |
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,83 | |
| 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,66 | |
| 236 | H03B | thyreostatika | parent. | H |
|---|
| 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,50 | H |
| 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA |
|---|
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 404,62 | L/DIA |
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA |
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | NOO | DK |
| 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END |
|---|
| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 104,13 | L/INT,ORT, END |